Sun X - Search Results

1

In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands.

Sun X, Kim J, Martell AE, Welch MJ, Anderson CJ. Sun X, et al. Nucl Med Biol. 2004 Nov;31(8):1051-9. doi: 10.1016/j.nucmedbio.2004.08.011. Nucl Med Biol. 2004. PMID: 15607487

2

Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ. Sun X, et al. J Med Chem. 2002 Jan 17;45(2):469-77. doi: 10.1021/jm0103817. J Med Chem. 2002. PMID: 11784151

3

In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.

Sun X, Wuest M, Kovacs Z, Sherry AD, Motekaitis R, Wang Z, Martell AE, Welch MJ, Anderson CJ. Sun X, et al. J Biol Inorg Chem. 2003 Jan;8(1-2):217-25. doi: 10.1007/s00775-002-0408-5. Epub 2002 Oct 11. J Biol Inorg Chem. 2003. PMID: 12459917

4

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ. Boswell CA, et al. Among authors: sun x. J Med Chem. 2004 Mar 11;47(6):1465-74. doi: 10.1021/jm030383m. J Med Chem. 2004. PMID: 14998334

5

Production and applications of copper-64 radiopharmaceuticals.

Sun X, Anderson CJ. Sun X, et al. Methods Enzymol. 2004;386:237-61. doi: 10.1016/S0076-6879(04)86011-7. Methods Enzymol. 2004. PMID: 15120255 No abstract available.

6

Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.

Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ. Sprague JE, et al. Among authors: sun x. Clin Cancer Res. 2004 Dec 15;10(24):8674-82. doi: 10.1158/1078-0432.CCR-04-1084. Clin Cancer Res. 2004. PMID: 15623652

7

MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids.

Sun X, Fang H, Li X, Rossin R, Welch MJ, Taylor JS. Sun X, et al. Bioconjug Chem. 2005 Mar-Apr;16(2):294-305. doi: 10.1021/bc049783u. Bioconjug Chem. 2005. PMID: 15769082

8

64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.

Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ. Rossin R, et al. Among authors: sun x. J Nucl Med. 2005 Jul;46(7):1210-8. J Nucl Med. 2005. PMID: 16000291 Free article.

9

An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.

Sun X, Rossin R, Turner JL, Becker ML, Joralemon MJ, Welch MJ, Wooley KL. Sun X, et al. Biomacromolecules. 2005 Sep-Oct;6(5):2541-54. doi: 10.1021/bm050260e. Biomacromolecules. 2005. PMID: 16153091 Free PMC article.

10

Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.

Ruangma A, Bai B, Lewis JS, Sun X, Welch MJ, Leahy R, Laforest R. Ruangma A, et al. Among authors: sun x. Nucl Med Biol. 2006 Feb;33(2):217-26. doi: 10.1016/j.nucmedbio.2005.11.001. Nucl Med Biol. 2006. PMID: 16546676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,064 results

Search Page

Filters